Leading a Novel Approach to Targeting the Microbiome

Kaleido Biosciences is a clinical-stage healthcare company with a chemistry-driven approach to targeting the microbiome to treat disease and improve human health.

Discovery & Development Model

Enables rapid advancement into human clinical studies

Learn about our proprietary product platform


Broad Pipeline

Candidates addressing a variety of diseases and conditions with high unmet needs

View our pipeline


Exceptional Team

Committed to scientific innovation, transforming lives and fostering a strong culture

Join the team